Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background Tuberculous meningitis (TBM) frequently presents with hyponatremia. However, its relation with disease severity and patient outcomes remains poorly understood. Methods In a prospective cohort study of adult TBM patients in Indonesia, we investigated the prevalence and prognostic significance of hyponatremia, defined as moderate (120-130 mEq/L) or severe (<120 mEq/L). All patients received anti-tuberculous therapy and corticosteroids. Patients were followed for mortality during and after hospitalization for 365 days. Results Among 864 adult TBM patients (median age 30 years, 60.5% male, 14.9% HIV-infected), 750 (86.8%) had hyponatremia, of whom 26% had severe hyponatremia (<120 mEq/L). Severe hyponatremia was associated with male, younger age, a lower Glasgow Coma Scale (GCS), concomitant pulmonary tuberculosis culture-confirmed TBM, higher cerebrospinal fluid (CSF) neutrophil count and protein, lower CSF/blood glucose ratio, anemia, blood leukocytosis, neutrophilia, and lymphopenia (p <0.05). One-year mortality was 46.5 % and associated with older age, HIV infection, lower GCS at presentation, markers of neurological severity, fever, and thrombocytosis. Severe hyponatremia was associated with increased mortality in univariate analysis in HIV-negative patients, but not in multivariate analysis, and not in HIV-positive patients. Conclusions Hyponatremia is common in patients with TBM and is associated with clinical severity, CSF and blood inflammation, and death. However, in our setting, hyponatremia does not independently contribute to increased mortality, and aggressive correction of hyponatremia is therefore unlikely to improve prognosis.
Background Tuberculous meningitis (TBM) frequently presents with hyponatremia. However, its relation with disease severity and patient outcomes remains poorly understood. Methods In a prospective cohort study of adult TBM patients in Indonesia, we investigated the prevalence and prognostic significance of hyponatremia, defined as moderate (120-130 mEq/L) or severe (<120 mEq/L). All patients received anti-tuberculous therapy and corticosteroids. Patients were followed for mortality during and after hospitalization for 365 days. Results Among 864 adult TBM patients (median age 30 years, 60.5% male, 14.9% HIV-infected), 750 (86.8%) had hyponatremia, of whom 26% had severe hyponatremia (<120 mEq/L). Severe hyponatremia was associated with male, younger age, a lower Glasgow Coma Scale (GCS), concomitant pulmonary tuberculosis culture-confirmed TBM, higher cerebrospinal fluid (CSF) neutrophil count and protein, lower CSF/blood glucose ratio, anemia, blood leukocytosis, neutrophilia, and lymphopenia (p <0.05). One-year mortality was 46.5 % and associated with older age, HIV infection, lower GCS at presentation, markers of neurological severity, fever, and thrombocytosis. Severe hyponatremia was associated with increased mortality in univariate analysis in HIV-negative patients, but not in multivariate analysis, and not in HIV-positive patients. Conclusions Hyponatremia is common in patients with TBM and is associated with clinical severity, CSF and blood inflammation, and death. However, in our setting, hyponatremia does not independently contribute to increased mortality, and aggressive correction of hyponatremia is therefore unlikely to improve prognosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.